Medicines
SmPC of 20/09/2013
ACTICARBINE, coated tablet
Composition
Activated charcoal ....................................................................................................................................................70,000 mg
Papaverine hydrochloride ..............................................................................................................................14,000 mg
For one coated tablet
Alginic acid, sucrose, maize starch, liquid glucose, polyethylene glycol 6000, magnesium stearate, bleached shellac, talc, gum arabic, titanium dioxide, carnauba wax
Dosage and administration
Reserved for adults
1 to 2 tablets before 3 meals, to be swallowed whole with a glass of water.
Contraindications
This medicine must not be used in cases of hypersensitivity to any of the constituents.
This medicine should generally not be used during pregnancy.
Warnings and precautions
In cases of associated diarrhoea, the need for rehydration should be assessed.
The extent of rehydration by oral rehydration solution or by intravenous route must be adapted according to the intensity of the diarrhoea, the age and the particularities of the patient (associated diseases…).
Interactions
Due to the properties of charcoal, the potential reduction in drug absorption means that any other medication should be administered at a distance (more than 2 hours, if possible) from the intake of this medicine.
Fertility, pregnancy and breastfeeding
Pregnancy
In the absence of reliable experimental data and in the absence of clinical experience with papaverine, use of this medicine is not recommended during pregnancy.
Breast-feeding
In the absence of data on the passage of papaverine into milk, this medicine should be avoided during breastfeeding.
Driving and using machines
Attention is drawn, particularly for drivers of vehicles and users of machinery, to the risks of drowsiness due to the presence of papaverine.
Overdose
No cases of overdose have been reported with this medicine. Papaverine, at very high doses, risks causing nausea, vomiting, weakness, central nervous system depression, nystagmus, diplopia, diaphoresis, facial flushing, dry mouth, dizziness and sinus tachycardia.
Pharmacodynamics
Pharmacotherapeutic class:
INTESTINAL ADSORBENT
ANTISPASMODIC
(A: alimentary tract and metabolism)
Association of activated charcoal and papaverine
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
181-183 RUE ANDRÉ KARMAN
93300 AUBERVILLIERS CEDEX
Tel: 01 48 34 75 03 laboratoire-elerte@orange.fr
https://www.elerte.fr/
Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.
